Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer

被引:43
作者
Tsao, MS
Yang, Y
Marcus, A
Liu, N
Mou, L
机构
[1] Univ Toronto, Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Princess Margaret Hosp, Ontario Canc Inst, Div Mol & Cellular Biol, Toronto, ON M4X 1K9, Canada
关键词
lung cancer; scatter factor; in situ hybridization; immunohistochemistry; metastasis;
D O I
10.1053/hupa.2001.21133
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hepatocyte growth factor (NGF) exerts multifunctional regulatory roles in the growth, morphogenesis, differentiation, and motility of epithelial cells, and putatively plays important roles in tumor angiogenesis and metastasis. Aside from the full-length protein, 2 naturally occurring truncated HGF isoforms (NK1 and NK2) have been identified, Recent evidence suggests that a high level of HGF in surgically resected non-small-cell lung carcinoma (NSCLC) is a negative prognostic marker for NSCLC patients' survival. The origin of HGF in these tumors remains uncertain. We show here by in situ hybridization and immunohistochemistry that HGF messenger RNA (mRNA) and protein were predominantly expressed by the tumor cells in a high percentage of primary NSCLC. Stromal cell expression of HGF,vas limited to some lymphocytes and endothelial cells. Normal bronchial and bronchiolar epithelial cells also expressed HGF mRNA and immunoreactive protein. The mRNA transcripts and putative proteins of all 3 known HGF isoforms were detected in both normal lung and lung cancer tissues, but the full-length HGF was predominantly expressed. Our findings indicate that both autocrine and paracrine functions of HGF are likely to contribute to the pathobiology of lung cancer in vivo. Copyright (C) 2001 by W.B. Saunders Company.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 47 条
[1]   IDENTIFICATION OF A COMPETITIVE HGF ANTAGONIST ENCODED BY AN ALTERNATIVE TRANSCRIPT [J].
CHAN, AML ;
RUBIN, JS ;
BOTTARO, DP ;
HIRSCHFIELD, DW ;
CHEDID, M ;
AARONSON, SA .
SCIENCE, 1991, 254 (5036) :1382-1385
[2]   Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF scatter factor variant with partial agonist antagonist activity [J].
Cioce, V ;
Csaky, KG ;
Chan, AML ;
Bottaro, DP ;
Taylor, WG ;
Jensen, R ;
Aaronson, SA ;
Rubin, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :13110-13115
[3]  
DIRENZO MF, 1991, ONCOGENE, V6, P1997
[4]  
Fleming ID, 1997, AJCC CANC STAGING MA, P127
[5]  
FURUKAWA T, 1995, AM J PATHOL, V147, P889
[6]   PURIFICATION OF SCATTER FACTOR, A FIBROBLAST-DERIVED BASIC-PROTEIN THAT MODULATES EPITHELIAL INTERACTIONS AND MOVEMENT [J].
GHERARDI, E ;
GRAY, J ;
STOKER, M ;
PERRYMAN, M ;
FURLONG, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5844-5848
[7]  
Harvey P, 1996, J PATHOL, V180, P389
[8]   Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance [J].
Ichimura, E ;
Maeshima, A ;
Nakajima, T ;
Nakamura, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (10) :1063-1069
[9]   AUTOCRINE STIMULATION OF MOTILITY IN SBC-5 HUMAN LUNG-CARCINOMA CELLS BY A 2-KRINGLE VARIANT OF HGF [J].
ITAKURA, Y ;
YAMAMOTO, T ;
MATSUMOTO, K ;
NAKAMURA, T .
CANCER LETTERS, 1994, 83 (1-2) :235-243
[10]   NK1, a natural splice variant of hepatocyte growth factor scatter factor, is a partial agonist in vivo [J].
Jakubczak, JL ;
LaRochelle, WJ ;
Merlino, G .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (03) :1275-1283